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Abstract
Background: The pituitary is a critical neuroendocrine gland that is comprised of five hormone-secreting
cell types, which develops in tandem during the embryonic stage. Some essential genes have been identified
in the early stage of adenohypophysial development, such as PITX1, FGF8, BMP4 and SF-1. However, it is
likely that a large number of signaling molecules and transcription factors essential for determination and
terminal differentiation of specific cell types remain unidentified. High-throughput methods such as
microarray analysis may facilitate the measurement of gene transcriptional levels, while Expressed
sequence tag (EST) sequencing, an efficient method for gene discovery and expression level analysis, may
no-redundantly help to understand gene expression patterns during development.
Results: A total of 9,271 ESTs were generated from both fetal and adult pituitaries, and assigned into 961
gene/EST clusters in fetal and 2,747 in adult pituitary by homology analysis. The transcription maps derived
from these data indicated that developmentally relevant genes, such as Sox4, ST13 and ZNF185, were
dominant in the cDNA library of fetal pituitary, while hormones and hormone-associated genes, such as
GH1, GH2, POMC, LHβ, CHGA and CHGB, were dominant in adult pituitary. Furthermore, by using RT-
PCR and in situ hybridization, Sox4 was found to be one of the main transcription factors expressed in fetal
pituitary for the first time. It was expressed at least at E12.5, but decreased after E17.5. In addition, 40
novel ESTs were identified specifically in this tissue.
Conclusion: The significant changes in gene expression in both tissues suggest a distinct and dynamic
switch between embryonic and adult pituitaries. All these data along with Sox4 should be confirmed to
further understand the community of multiple signaling pathways that act as a cooperative network that
regulates maturation of the pituitary. It was also suggested that EST sequencing is an efficient means of
gene discovery.
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Background
The pituitary is well known as one of the most important
glands in the endocrine system, and secretes hormones
that orchestrate many physiological processes such as
growth, sexual development, metabolism and the stress
response. It contains three lobes and is of dual embryonic
origin [1]. The posterior lobe is of neuroectodermal origin
while the anterior and intermediate lobes are of ectoder-
mal origin. The anterior pituitary gland consists of five cell
types: somatotrophs [producing growth hormone (GH)],
lactotrophs [producing prolactin (PRL)], gonadotrophs
[producing luteinizing hormone (LH) and follicle stimu-
lating hormone (FSH)], thyrotrophs [producing thyroid
stimulating hormone (TSH)], and corticotrophs [produc-
ing adrenocorticotropic hormone (ACTH), proteolytically
cleaved from proopiomelanocortin (POMC)]. Melano-
trophs [producing melanocyte-stimulating hormone
(MSH)], proteolytically cleaved from POMC are the sixth
hormone-producing cell type, but these are situated
within the intermediate lobe. During embryonic develop-
ment, the six specific cell types arise from Rathke's pouch
(RP), and form the anterior and intermediate lobes under
the control of various mechanisms [2].
In the past several years, most aspects of pituitary develop-
ment have been extensively explored, because of the rela-
tively simple structure of the gland and its critical role in
the neuroendocrine system [3]. According to the struc-
tural changes and cell-type-specific occurrence, develop-
ment and differentiation of the pituitary can be divided
into three major stages [4,5]. The onset of pituitary orga-
nogenesis is marked by a striking restriction of Shh,
BMP4, FGF8 and Wnt5a, which are uniformly expressed
in the oral ectoderm from the invaginating RP. In murine
embryos, this is formed around E9.0, which results in a
molecular boundary in the oral ectoderm [6,7]. The sec-
ond phase of pituitary development appears to involve
BMP2, Wnt4, and Prop1 expression, which participate in
the progression from organ commitment to cell-type
determination that occurs between E10 and E12. At this
time, the RP extends dorsally and expands to form a flat-
tened epithelium close to the infundibular recess of the
diencephalon. Hes1 and Hes5 have been identified to
play a role in controlling the progenitor pool, intermedi-
ate lobe specification, and posterior lobe formation dur-
ing pituitary development [8]. Terminal differentiation of
the hormone-secreting cells occurs after E12 and is
marked by the expression of LH and FSH in gonado-
trophs, GH in somatotrophs, and PRL in lactotrophs.
Transcription factors like Prop1, TBX19, Gata2 and
POU1F1 are necessary for the terminal differentiation
events and cell-type-specific gene expression [9].
Three recent studies using cDNA microarray have been
carried out to profile gene expression pattern during pitu-
itary development [10-12]. Many genes, such as carbox-
ypeptidase E (CPE), stathmin (STMN1), endothelin type
A receptor (EDNRA), dual-specificity phosphatase 1
(DUSP1), FGF2, FGF4, ZHX1B, DUSP3 and Sox10, were
newly identified as being involved in the determination
and cell-type-specific gene expression of the six mature
endocrine cell types. It has been suggested that a large
number of signaling molecules and transcription factors
essential for pituitary development remain unclear, espe-
cially at the end of differentiation. All these large-scale
studies were carried out based on neuroendocrine-system-
specific cDNA microarrays. In addition, it is necessary to
point out that the understanding of pituitary develop-
ment and the regulatory programs that control hormone
expression have been mostly derived from animal experi-
ments, in particular mice and chickens. Accumulating evi-
dence has implied that there are vital differences in gene
expression profiles between development in mice and
humans [13,14]. Until now, there has been a lack of infor-
mation from expressed sequence tag (EST) libraries of
human fetal pituitary.
For a comprehensive insight into the molecular mecha-
nisms involved in human pituitary development, we used
a relatively large number of ESTs to investigate the differ-
entially expressed genes/ESTs in fetal and adult pituitaries.
In addition to data from microarrays, the EST data
reported herein will lead to an additional understanding
of human pituitary development and hormone expres-
sion.
Results
General characteristics of ESTs derived from human 
pituitaries
To profile the gene expression of fetal pituitary, 4,172
clones from the cDNA library were randomly selected and
sequenced from the 5' end. After removing rRNA, as well
as repetitive, mitochondrial and ambiguous sequences,
3,394 (81.4%) high-quality ESTs were obtained and fur-
ther analyzed. Assembling of all available ESTs generated
961 cluster sets including 774 singleton (did not cluster
with anything else) and 187 non-singleton clusters. They
were deposited GenBank in NCBI with accession num-
bers: CD236662–CD240055. The average cluster con-
tained 3.53 sequences. Of which, 757 (78.7%) and 123
(12.8%) were matched known genes and ESTs, respec-
tively. The remaining 82 (8.5%) were considered as novel
ESTs, because they did not match with any known genes
or ESTs (Fig. 1A). The previous 5,877 ESTs that we gener-
ated from adult pituitary glands [15] were analyzed again
and grouped into 2,747 clusters. Of which, 2,594
(87.0%), 344 (11.5%) and 45 (1.5%) were respectively
identified as known genes, known ESTs and unique ESTs
found only in the pituitary cDNA libraries (Fig. 1B).
Although a total of 3,539 EST clusters were derived fromBMC Genomics 2009, 10:109 http://www.biomedcentral.com/1471-2164/10/109
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human pituitaries, only 169 (4.8%) genes or ESTs were
shared in both cDNA resources, which suggested that
there might have been a significant switch of pituitary
functions during development because of the differential
gene expression profiles between fetal and adult pituitar-
ies (Fig. 1C).
Screening of developmentally relevant genes
Using the data from EST sequencing, we could distinguish
the potential development-associated genes from the gene
expression profiles, particularly, genes that were expressed
highly in the human fetus. In the first 20 genes expressed
highly in both fetal and adult pituitaries (Table 1), tissue-
specific functional markers, such as GH, PRL, and glyco-
protein hormones alpha (CGA), were frequently encoun-
tered in both tissues, which reflected the basic pituitary
functions.
Except for POU1F1, the pituitary-specific transcription
factor, some development-associated genes, such as Sox4,
suppression of tumorigenicity 13 (ST13) and fucosyl-
transferase 2, were highly expressed in fetal pituitary,
which implies that these genes are involved in pituitary
development. By comparing both cDNA resources, a total
of 111 (3.1%) clusters were significantly differently
expressed in fetal and adult pituitaries (p < 0.05) (See
Additional file 1), including olfactory receptor 5, Hsp70-
interacting protein, RAB9, heparin binding growth factor
8, EDNRA and mitogen-activated protein kinase phos-
phatase x, which were highly expressed in the fetus. Also,
GA-bingding protein transcription factor (GABP),
hypoxia-inducible factor 1 (HIF-1), and transcription fac-
tor DP3 (TFDP3) were presented in the fetal pituitary EST
library.
Expression pattern of Sox4
There were eight (0.24%) transcripts for Sox4 in the fetal
pituitary ESTs, but none was found in the adult pituitary
cDNA library. The expression pattern of Sox4 during pitu-
itary development was confirmed by semi-quantitative
RT-PCR of human samples. The transcript level of Sox4
was much higher in fetal pituitary but was reduced to a
very low level in adult pituitary (Fig. 2). At the same time,
the transcription levels of GH, PRL, POMC, TSH, FSH, LH,
CGA and CART (cocaine and amphetamine regulated
transcript) were increased in adult samples. To further
address the issue, we examined expression of Sox4 in
E12.5, E14.5 and E17.5 mouse embryos and in adult pitu-
itary using in situ hybridization. On E12.5, Sox4 was
expressed in the pituitary at modest levels in the
infundibulum and RP (Fig. 3A). By E14.5, Sox4 expres-
sion was most abundant in the undifferentiated cells of
the anterior, intermediate and posterior lobes (Fig. 3B),
but significantly decreased at E17.5 (Fig. 3C). In adults,
the pituitary is fully differentiated and contains all of the
hormone-secreting cell lineages. At this time-point, Sox4
was not detected in either the anterior, intermediate or
posterior lobes (Fig. 3D). The expression pattern was sim-
ilar to that of the gene in pancreas [16] and tibia [17]
development, which indicates that the activity of this gene
is restricted to the cell specification and terminal differen-
tiation phase of pituitary development.
Homologous analysis of EST clusters from human pituitaries Figure 1
Homologous analysis of EST clusters from human pituitaries. (A) 961 EST clusters were generated from fetal pituitary 
using software CAT 3.5 (Pangea) with default parameters, and classified as the known genes, known ESTs and novel ESTs by 
searching against public DNA and protein databases. Novel EST clusters indicated that no known human genes and ESTs in 
public databases shared identity with the ESTs. (B) Distribution of 2747 EST clusters from adult pituitary based on homology 
analysis. (C) Overlapping of EST clusters from fetal and adult pituitaries. Overlapping region indicates the numbers of EST clus-
ters shared by both cDNA resources, while the other numbers represent EST clusters found only in fetal or adult cDNA 
libraries.BMC Genomics 2009, 10:109 http://www.biomedcentral.com/1471-2164/10/109
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Tissue expression patterns of novel ESTs
The present study generated 82 novel ESTs. They did not
show homologous with any known genes/ESTs or pro-
teins of any species but human genomic DNA by search-
ing against nucleotide collection (nr/nt) database on
NCBI. Also they are all presented as singleton clusters. To
establish potential functions, the tissue expression pat-
terns of 40 selected novel ESTs were evaluated by semi-
quantitative RT-PCR (Fig. 4). Most of these ESTs were
expressed in a limited manner in certain tissues, and not
ubiquitously in all 10 tissues examined. Interestingly,
some transcripts, such as CD239423, CD239425,
CD238497 and CD238482, were highly expressed in pitu-
itary glands and testes. Meanwhile, some ESTs, such as
CD237004, CD236818 and CD237414 were specifically
expressed in the brain, in addition to the pituitary. The
expression of CD237004, CD238497 and CD239425 was
further confirmed by in situ hybridization with human
Table 1: The first 20 known genes expressed highly in human pituitaries based on EST data
Unigene No. Gene name Copies %*
Fetal pituitary
Hs.1905 prolactin+# 312 9.46
Hs.119689 glycoprotein hormones, alpha +# 146 4.43
Hs.115352 growth hormone 1+# 48 1.46
Hs.274460 olfactory receptor 5V1# 48 1.46
Hs.195453 ribosomal protein S27+# 24 0.73
Hs.75415 beta-2-microglobulin+# 22 0.67
Hs.70312 cytochrome c oxidase 7A2+# 15 0.46
Hs.315164 hypothetical protein# 14 0.42
Hs.83484 sex determining region Y-box 4# 8 0.24
Hs.7917 DKFZP564K247 protein# 7 0.21
Hs.273385 guanine nucleotide binding protein alpha+# 7 0.21
Hs.165590 ribosomal protein S13# 7 0.21
Hs.131814 tankyrase# 7 0.21
Hs.173912 eukaryotic translation initiation factor+ 6 0.18
Hs.119222 suppression of tumorigenicity 13+# 6 0.18
Hs.177530 ATP synthase+ 5 0.15
Hs.177656 calmodulin 1+ 5 0.15
Hs.241429 cDNA DKFZp586C1923# 5 0.12
Hs.330994 RAB9# 4 0.12
Hs.46328 fucosyltransferase 2# 4 0.12
Adult pituitary
Hs.115352 growth hormone 1+# 358 6.09
Hs.1905 prolactin+# 288 4.9
Hs.1897 proopiomelanocortin# 46 0.78
Hs.181165 eukaryotic translation elongation factor1# 45 0.77
Hs.273385 guanine nucleotide binding protein AS1+# 44 0.75
Hs.65149 growth hormone 2# 42 0.71
Hs.279789 glucose phosphate isomerase# 41 0.7
Hs.119689 glycoprotein hormones, alpha+# 37 0.63
Hs.77385 myosin, light polypeptide 6+# 30 0.51
Hs.278959 galanin-related peptide LOC51083# 25 0.43
Hs.247474 hypothetical protein FLJ21032# 21 0.36
Hs.180450 ribosomal protein S24# 20 0.34
Hs.155482 hydroxyacyl glutathione hydrolase# 19 0.32
Hs.76053 DEAD/H box polypeptide 5# 19 0.32
Hs.75360 carboxypeptidase E+# 18 0.31
Hs.112844 maternally expressed 3# 16 0.27
Hs.117950 phosphoribosylaminoimidazole carboxylase# 16 0.27
Hs.119598 ribosomal protein L3# 16 0.27
Hs.5464 skeletal muscle abundant protein# 16 0.27
Hs.179526 thioredoxin interacting protein # 15 0.26
* Percentage of a given EST in all ESTs obtained from that of cDNA libraries.
+ The genes presented in the EST libraries of both fetal and adult pituitary.
# Significant differences in gene expression (P < 0.05) between fetal and adult pituitaries http://igs-server.cnrs-mrs.fr.BMC Genomics 2009, 10:109 http://www.biomedcentral.com/1471-2164/10/109
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fetal pituitary tissues (Fig. 5). There were positive signals
(blue spot) in all the sections hybridized with anti-sense
probes.
Discussion
Previous studies on the pituitary have focused on individ-
ual genes and signaling pathways involved in its develop-
ment [4,18,19], as well as expression and release of
pituitary hormones, such as PRL, LH and FSH [20,21].
With the advance of the human genome project, a large
amount of genomic information is now available for sur-
veying the physiological and pathological processes of
humans at a global level. Hormonal genomics has been
proposed to develop postgenomic approaches substitut-
ing gene-by-gene ones to reveal the subfamilies and path-
ways for genes involved in the hormones signaling [22].
The functional subgenomes of secreted extracellular sign-
aling molecules, transmembrane receptors, intracellular
signaling molecules, and transcriptional factors can now
be analyzed in an integrated manner. Of which, EST
sequencing, series analysis of gene expression (SAGE) and
cDNA microarray or gene chip analysis are the most effi-
cient strategies for profiling gene expression at the tran-
scriptome level [23-25].
In this study, a total of 3,539 EST clusters were derived
from 9,271 ESTs generated from cDNA libraries of human
fetal and adult pituitaries. It was not as high as expected
because of the limited number of human samples. We did
confirm the information by semi-quantitative RT-PCR, in
situ  hybridization or reviewing previous studies. Aside
from semi-quantitative RT-PCR in this study, microarray
analysis and quantitative RT-PCR carried out in our previ-
ous study also showed that the expression level of hor-
mones, such as TSHβ, POMC and GH in fetus, were
relative lower than that in adult [11]. On the other hand,
some genes such as EDNRA, were highly expressed in fetal
pituitary, also in agreement with previous study per-
Evaluating the expression pattern of selected known genes in  fetal and adult pituitaries by semi-quantitative RT-PCR Figure 2
Evaluating the expression pattern of selected known 
genes in fetal and adult pituitaries by semi-quantita-
tive RT-PCR. Relative transcriptional levels of some known 
genes, such as GH, PRL, POMC, CGA, TSH-β, LH-β, FSH-β, 
CART and SOX4 were analyzed by electrophoresis. F, fetal 
pituitary; A, adult pituitary.
In situ hybridization of Sox4 in mice fetal pituitaries Figure 3
In situ hybridization of Sox4 in mice fetal pituitaries. 
A-D show the images hybridized with Sox4 probe. The posi-
tive blue color was initiated by alkaline phosphatase and 
BCIP/NBT. All the slides were counterstained with 0.1% 
nuclear fast red after in situ hybridization. Original magnifica-
tion, ×200 (bar, 50 μm).
Tissue expression patterns of 40 novel ESTs from human  fetal pituitary Figure 4
Tissue expression patterns of 40 novel ESTs from 
human fetal pituitary. Relative levels of novel ESTs in dif-
ferent tissues were evaluated by semi-quantitative RT-PCR, 
and were represented as color boxes with shades on a scale 
based on the average ratio of the density of PCR product 
band between the experimental gene and reference gene β-
actin. The patterns were clustered and viewed using Gene 
Cluster and TreeView software (Stanford University). The 
relatively pituitary-specific ESTs were indicated by words in 
red. 1, heart; 2, spleen; 3, lung; 4, muscle; 5, brain; 6, fetal 
pituitary; 7, testis; 8, kidney; 9, thymus; 10, small intestine.BMC Genomics 2009, 10:109 http://www.biomedcentral.com/1471-2164/10/109
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formed by Dr. Ellestad using microarray [12]. Although
these studies were all to highlight the gene expression pro-
file of pituitary, there is only few genes overlapped
between these screens. Most of the variations could be
caused by methods different.
The partial transcription maps derived from these ESTs
indicated that hormones and hormone-associated genes
were predominant in adult pituitary, while development-
associated genes were predominant in fetal pituitary,
including Sox4 and ST13. Sox4 has been shown to be
functionally involved in development of a wide range of
tissues and cells, such as heart, B cells, reproductive system
and central nervous system [26]. ST13 may facilitate the
chaperone function of Hsc/Hsp70 in protein folding and
repair, and in controlling the activity of regulatory pro-
teins such as steroid receptors and regulators of prolifera-
tion or apoptosis [27,28]. POU1F1, necessary for cell
lineage of thyrotrophs, somatotrophs and lactotrophs,
was hit once in the cDNA library of fetal pituitary. No sig-
nificant different of its expression level could be detected
between fetal and adult pituitary. It is in agreement with
that POU1F1 is necessary but not sufficient for hormones
gene activation [29].
It was revealed for the first time that Sox4, a member of
the SRY-like high-mobility group (HMG) box gene family,
was one of the most abundant mRNAs in the fetal pitui-
tary. The HMG box defines a superfamily of eukaryotic
DNA-binding proteins of central importance in mamma-
lian gene regulation [30], and SRY defines the mamma-
lian testis-determining factor encoded by the Y
chromosome [31]. Sox protein is a specific HMG-box fac-
tor that is similar to SRY. It is ubiquitous in the animal
kingdom and is involved in diverse developmental proc-
esses, including germ layer formation, cell type specifica-
tion, and organogenesis [32]. Sox4 null mice die during
embryogenesis because of failure of endocardial ridge
development, and blocking of B-cell lineage progression
at the stage of pro-B-lymphocyte expansion [33].
Explanted fetal thymic organ cultures (FTOCs) of Sox-4-
deficient thymus yielded 10–50-fold fewer CD4/CD8
double-positive and single-positive cells than FTOCs of
littermates [34]. Lioubinski et al have reported that Sox4
is expressed in insulin-producing pancreas islets, and co-
expressed with glucagon during tissue development [16].
Also, it has been reported that Sox4 is expressed in the
mouse uterus under ovarian hormone control. This sug-
gests a developmental role for this gene in the female
reproductive system, because its expression always
appears to be related to the maturational stage of the cell
population [35]. Furthermore, Cheung et al [26] showed
that Sox4 might indeed had another functional role in
brain development. It has been demonstrated that Sox4
expression counteracts differentiation of radial glia and
has to be down-regulated before full maturation can occur
in the brain [36]. Radial glia with prolonged expression of
Sox4 fail to migrate to the position normally assumed by
Bergmann glia, and do not extend radial fibers toward the
pial surface [37]. The expression pattern of Sox4 in pitui-
tary development suggests that it is involved in pituitary
cell differentiation; similar to its role in facilitating thy-
mocyte differentiation, but it normally prevents prema-
ture differentiation of human pituitary.
In addition, we investigated the expression of 17 members
of the Sox gene family in the fetal human pituitary using
RT-PCR. Eleven of these members (Sox 2, 3, 4, 5, 7, 9, 10,
12, 13, 15 and 17) were detected (data not shown). It has
recently been reported that Sox2 had a critical role in the
development of the hypothalamo-pituitary axis [38,39],
and deletion of Sox3 can lead to abnormal development
of RP and defects in pituitary function [39,40]. Sox10
might be necessary for gonadotropin-releasing hormone
cell differentiation [41]. Obviously, members of the Sox
In situ hybridization of novel ESTs in human fetal pituitaries Figure 5
In situ hybridization of novel ESTs in human fetal 
pituitaries. Expression of ESTs and GH as a control was 
detected by sense and anti-sense RNA probes, respectively. 
The positive blue color was initiated by alkaline phosphatase 
and BCIP/NBT. All the slides were counterstained with 0.1% 
nuclear fast red after in situ hybridization. Original magnifica-
tion, ×400.BMC Genomics 2009, 10:109 http://www.biomedcentral.com/1471-2164/10/109
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gene family might have a predominant role in the regula-
tion of hypothalamus-pituitary axis formation.
Except for the genes known to be associated with pituitary
development, our data suggest that some other genes are
involved in the differentiation and maturation of human
pituitary. They contained genes for cytokines and their
receptors, transcription factors, and those involved in the
cell cycle, DNA replication and signal transduction. Of
which, GA-binding protein transcription factor is a critical
and functionally relevant Ets factor that regulates rPRL
promoter activity via the BTE site [42]. HIF-1 exerts an
antiapoptotic role in HP75 in hypoxia [43]. TFDP3 was
identified in pituitary for the first time, and only highly
espressed in human testis, thymus and fetal pituitary
according to our studies (data not show). It was reported
as an inhibitor of E2F-induced apoptosis [44].
40 novel ESTs were produced in human fetal pituitary.
They are all singletons which no EST was matched in a
BLAST against the nonredundant EST database at NCBI. It
is suggested that they are potential new genes, proteins
and microRNAs that need to be investigated in the future.
For example, CD239423 was located on Human DNA
sequence from clone RP11-123K19 on chromosome 9,
jointed by 13118–13292, 26649–26703, 29319–29386,
and 39381–39729. The others such as CD239425,
CD238497, CD237004 and CD238482 were found to
reside in the introns of various genes. And their tissue
expression patterns show that some novel ESTs exist par-
ticularly in fetal pituitary cells. It is indicated that EST
sequencing is an efficient method for gene discovery and
expression level analysis.
Conclusion
In conclusion, the transcriptome approaches used in this
study indicate some novel clues in human pituitary devel-
opment. Of these, Sox4 and some novel ESTs are sug-
gested to have important roles in pituitary development.
Thus, the EST data was effective for identifying a compre-
hensive gene expression profile. It may lay the foundation
for further investigation of the molecular mechanisms of
human pituitary development and function.
Methods
Specimens
Two male fetal pituitaries were obtained from 16-week-
old human fetuses, which were aborted accidentally with-
out genetic, immunologic and infections diseases. The
local ethical committee of Xijing hospital proved this
study. The tissues were removed within 4 hours after abor-
tion, frozen in liquid nitrogen, and stored at -80°C.
C57BL/6 mouse embryos were obtained from the Animal
Center of the Fourth Military Medical University. All
human and animal subjects were treated according to rel-
evant ethical criteria and guidance of the ethics committee
in the university. Total RNAs of human adult heart,
spleen, lung, muscle, brain, testis, kidney, thymus, small
intestine and pituitary were bought from Clontech Com-
pany.
Extraction of RNA
Total RNA was extracted using TRIZOL Reagent (Life Tech-
nologies), and treated with DNase I at 37°C for 30 min-
utes, then purified with phenol-chloroform. After
extraction, the quality of total RNA was evaluated by elec-
trophoresis on 1% agarose gel containing ethidium bro-
mide, and the ratio of absorbance at 260/280 nm by
spectrophotometer (Beckman).
cDNA library construction and EST sequencing
A cDNA library from a 16-week-old male fetal pituitary
gland was constructed by using the SMART cDNA Library
Construction Kit (Clontech) according to the manufac-
turer's protocol. Briefly, 1.0 μg total RNA was used to syn-
thesize the first strand with a modified oligo(dT) primer
(CDS III/3' PCR Primer) and a short extended template
(SMART IV Oligo) at 42°C for 1 hour. PCR amplification
was carried out at 95°C for 5 seconds and 68°C for 6 min-
utes for 20 cycles using a PE9600 thermal cycler (Applied
Biosystems). After treating 50 μl PCR products with 40 μg
proteinase K at 45°C for 20 minutes to inactivate DNA
polymerase, and purifying with phenol/chloroform/iso-
amylalcohol, the products were digested by SfiI restriction
enzyme at 50°C for 2 hours. The SfiI-digested cDNA was
ligated to the SfiI-digested λTriplEx2 vector, and trans-
formed into Escherichia coli BM25.8 after λ-phage packag-
ing reaction. Bacterial colonies that contained cDNA
inserts were randomly selected and grown, and plasmid
extraction was performed in a 96-well format (Qiagen).
DNA sequencing reactions were performed in a 9600
Thermal Reactor (Perkin-Elmer) using a Dye Primer Cycle
Sequencing Kit (Perkin-Elmer). The DNA sequence reac-
tion of each clone was taken from the 5' end with the PT
primer (5'-ctc cga gat gtg gac gag c-3') on the 3700 Genetic
Analyzer (PE Biosystems).
EST database analysis and management
The qualified ESTs, which referred to those that contained
< 3% ambiguous bases and were longer than 100 bp, were
subjected to BLAST analysis. The EST was considered as
part of a known gene or EST if it shared 95% homology
with at least 100 bp of the known gene or EST, and the
ESTs with no match to human ESTs were considered to be
novel. All the ESTs were grouped into clusters of
sequences which were thought to encode for one gene or
EST, using the software CAT 3.5 (Pangea) with default
parameters. The genes and ESTs were localized on chro-
mosomes by searching the UniGene database http://
www.ncbi.nlm.nih.gov/sites/entrez?db=unigene and
genome information deposited in GenBank.BMC Genomics 2009, 10:109 http://www.biomedcentral.com/1471-2164/10/109
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Semi-quantitative RT-PCR
To confirm the expression and differentially transcrip-
tional level of some selected genes/ESTs, a semi-quantita-
tive RT-PCR was performed on fetal and adult RNA. The
RT reactions were performed using SuperScript II RNase H
reverse transcriptase (Invitrogen) according to the manu-
facturer's instructions. PCR amplification was carried out
with specific primers that corresponded to the selected
genes/ESTs, while β-actin was co-amplified as an internal
control in the same reaction. A first cycle of 10 minutes at
95°C, 40 seconds at 55°C and 50 seconds at 72°C was
followed by 40 seconds at 95°C for 30 cycles. The PCR
products were analyzed on 2% agarose gels. The transcrip-
tional levels of the genes were estimated according to the
average ratio of density integration between the band den-
sity of specific genes and internal controls.
In situ hybridization
5-μm tissue sections were made from paraffin blocks of
C57BL/6 mouse embryos, and 10-μm sections were made
from frozen human fetal pituitary tissue. Paraffin block
tissue sections were dewaxed in xylene and dehydrated
with increasing concentrations of ethanol, after mounting
on glass slides. Digoxigenin (DIG)-labeled antisense RNA
probes were prepared using DIG-UTP according to the
standard protocol of the T7/SP6 RNA DIG Labeling Kit
(Roche). All the procedures for in situ hybridization were
performed as described previously [45], except for the fol-
lowing modification: hybridization was carried out at
60°C overnight, the concentration of the labeling probe
was 1 ng/μl, and the slides were washed in 2 × SSC with
0.1 ng/ml RNase A at 37°C for 1 hour, followed by 2 ×
SSC at 60°C for 1 hour, and 0.2 × SSC at 60°C for 30 min-
utes. After blocking the slides, immunological detection
for DIG with anti-DIG-AP was performed according to the
instruction manual of the DIG Nucleic Acid Detection Kit
(Roche). The color reaction was initiated by the addition
of BCIP/NBT. Finally, the slides were counterstained with
0.1% nuclear fast red. The plasmid that contained Sox4
was kindly provided by Dr. Kaare M. Gautvik. All other
probes were generated by RT-PCR. The following regions
were used: mouse Sox4 (nt 30–408,), CD23847 (226–
670), CD239425 (128–711), and CD237004 (88–653).
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